NCT01462617View on ClinicalTrials.gov

Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557

PHASE1CompletedINTERVENTIONAL

Enrollment

61

Participants

Timeline

Start Date

July 24, 2011

Primary Completion Date

March 26, 2012

Study Completion Date

March 26, 2012

Conditions

Asthma

Interventions

DRUG

GSK2269557

Study Drug

DRUG

GSK2269557 matching placebo

Study Drug

Trial Locations (1)

SE1 1YR

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY